Inspire Medical Systems (INSP) Cash & Equivalents (2017 - 2026)

Inspire Medical Systems has disclosed Cash & Equivalents across 10 years of filings, most recently posting $127.8 million for Q2 2026.

• In Q2 2026, Cash & Equivalents rose 19.48% year-over-year to $127.8 million; the TTM figure through Jun 2026 stood at $127.8 million (up 19.48% YoY), while the FY2025 annual figure was $104.8 million, down 30.19% from the prior year.
• Cash & Equivalents came in at $127.8 million for Q2 2026 at Inspire Medical Systems, up from $98.9 million in the prior quarter.
• In the past five years, Cash & Equivalents ranged from a high of $467.1 million in Q2 2023 to a low of $53.9 million in Q1 2025.
• Average Cash & Equivalents over 5 years is $218.9 million, with a median of $180.5 million recorded in 2023.
• Year-over-year, Cash & Equivalents surged 150.34% in 2023 and plunged 69.28% in 2025.
• Over 5 years, Cash & Equivalents stood at $441.6 million in 2022, then slumped by 57.98% to $185.5 million in 2023, then fell by 19.07% to $150.2 million in 2024, then sank by 30.19% to $104.8 million in 2025, then grew by 21.89% to $127.8 million in 2026.
• Per Business Quant data, the three most recent Cash & Equivalents figures were $127.8 million in Q2 2026, $98.9 million in Q1 2026, and $104.8 million in Q4 2025.